Speaker Profile
PhD, Chief Genomics Officer, Broad Inst.
Biography
Stacey Gabriel is a human geneticist with a research interest in large scale genomics research. The organization that she leads operates as one of the largest sequencing centers in the world and continually explores, validates, optimizes, and implements new technologies, methods, and analysis tools to meet the needs of the scientific community. She has played a central role in the development of methods for generating and analyzing data using genomic technologies for both cancer and medical genetics studies. Her research on the haplotype structure of the human genome provided the foundation for the Human HapMap Project. She directs the Broad Institutes execution in flagship large scale projects including the Human HapMap, the 1000 Genomes Project, The Cancer Genome Atlas, and the All of Us Research Program. During the covid19 pandemic Dr. Gabriel led the development and execution of a commercial scale diagnostic testing and viral surveillance activity.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation
- Robert Sebra, ISMMS
- Anshul Kundaje, Stanford
- Chaz Langelier, UCSF
- Orly Alter, Prism AI Inc - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF
- Billy Tsz Cheong Lau, Stanford - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - New Frontiers in Genomic Analysis & Interpretation continues: AI in Spatial Transcriptomics in Patient Response
- David. W. Craig, City of Hope Cancer Center
- Premal Shah, MyOme - The Economic Perspective on Genomics (PANEL)
Chair: Bill Hyun, UCSF
- Steve Turner, PacBio
- Alex de Winter, Danaher Ventures
- Kandaswamy (Swamy) Vijayan, Zafrens - Using AI for Scalable Phenotyping and Discovery
- Andrew Carroll, Google
- Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos - NCI Showcase
- Xiaofeng Xie, MicrOmics Technologies
